Minimal Sample Size for Food Effect Study [Regulatives / Guidelines]

posted by Olivbood – France, 2019-06-14 08:42 (498 d 02:54 ago) – Posting: # 20325
Views: 1,477

Hello everyone,

I have a relatively quick question in regards to the FDA guideline "Assessing the Effects of Food on Drugs in INDs and NDAs — Clinical Pharmacology Considerations" dated February 2019.

The guideline specifies that "At a minimum, 12 subjects should be enrolled in each treatment arm." I deduce from it that this is the minimal sample size considering a parallel design study.
Alternatively, for a classic 2x2 cross-over study the minimal sample size should be 12 subjects in total since each subject will experience both fed and fasted status.

Is my understanding correct?

Many thanks,


Edit: Guidance linked. [Helmut]

Complete thread:

 Admin contact
21,179 posts in 4,414 threads, 1,474 registered users;
online 9 (0 registered, 9 guests [including 4 identified bots]).
Forum time: Saturday 11:36 UTC (Europe/Vienna)

It is the peculiar and perpetual error of the human understanding
to be more moved and excited by affirmatives than negatives.    Francis Bacon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz